ROYAL BANK OF CANADA - ANTHERA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$2,0000.0%6,594
+136.3%
0.00%
Q4 2016$2,0000.0%2,791
+203.4%
0.00%
Q3 2016$2,000
-66.7%
920
-48.6%
0.00%
Q2 2016$6,000
+50.0%
1,790
+79.0%
0.00%
Q1 2016$4,000
-20.0%
1,000
-8.9%
0.00%
Q4 2015$5,000
-72.2%
1,098
-62.8%
0.00%
Q3 2015$18,000
-35.7%
2,954
-7.7%
0.00%
Q2 2015$28,0003,200
+45614.3%
0.00%
Q1 2014$07
+40.0%
0.00%
Q3 2013$050.00%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Abingworth LLP 861,723$1,174,0000.98%
R&F Capital Advisors LP 171,205$111,0000.04%
Rhenman & Partners Asset Management AB 200,000$130,0000.02%
Rock Springs Capital Management LP 380,000$247,0000.02%
WHITE PINE CAPITAL LLC 35,000$23,0000.01%
BVF INC/IL 62,292$40,0000.01%
Virtu KCG Holdings LLC 271,239$176,0000.00%
TURNER INVESTMENTS LLC 15,000$10,0000.00%
TWO SIGMA SECURITIES, LLC 11,736$8,0000.00%
Tower Research Capital LLC (TRC) 36,413$24,0000.00%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders